New Issue: Orbital Catastrophe Ahead? Read Now

Certain Brain Cells Become Toxic in Lou Gehrig's Disease

Brain cells known for assisting neurons may be killing them in patients with ALS

Join Our Community of Science Lovers!


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is a progressive neuromuscular disease that affects about 130,000 people worldwide a year. The vast majority of patients are isolated cases with no known family history of the disease. They usually start developing symptoms of the loss of motor neurons in middle age and die within five years of diagnosis. Researchers know very little about what causes ALS. Now a recent study in Nature Biotechnology suggests that the neuron death associated with the disease may be caused by astrocytes, a type of brain cell that normally helps neurons.

Previous research had suggested that astrocytes could become toxic in the rare form of ALS known to have genetic roots, and the study authors wanted to see if a similar phenomenon might happen in the more common iso­­lated cases. The answer turned out to be yes: when they cultured astro­cytes from those ALS patients, the healthy motor neurons in the culture began to die off after a few days. Other types of neurons were unaffected by the astrocytes, suggesting that they specifically harm the neurons involved in controlling the body’s movements.

Lead author Brian Kaspar, a neuroscientist at Ohio State University, and his collaborators next will attempt to figure out what makes the astrocytes behave this way. If researchers can understand why motor neurons die in ALS, they may have a better chance of finding a cure.

Erica Westly is an author and journalist based in Seattle. Her work has appeared in Scientific American, Nature Medicine and the New York Times, among other outlets.

More by Erica Westly
SA Mind Vol 22 Issue 6This article was published with the title “When Helper Cells Attack” in SA Mind Vol. 22 No. 6 (), p. 7
doi:10.1038/scientificamericanmind0112-7a

Subscribe to Support Independent Journalism

Great science journalism requires human expertise, time, effort and creativity. And it costs money. That’s why I and the journalists here at Scientific American hope you’ll join our community.

When you subscribe, you are supporting staff and freelance journalists who are passionate about telling science stories that are true, important and compelling. Our editors and reporters are often experts in their fields, which means they understand the nuances of big discoveries and can untangle the breakthroughs from the hype. With a subscription, you are also supporting rigorous fact-checking to ensure the words we publish are precise and accurate. And you’re supporting original illustrations, graphics and photos that bring you closer to an advanced laboratory, an ice sheet in Antarctica or a space mission in orbit. You’re helping us craft other types of high-quality journalism as well: Our newsletters are carefully written, edited and curated by staffers you have or will come to know and love. Our Science Quickly podcast is based on original reporting, collaboration with editors and scientists and exacting production.

Subscriptions keep this engine running so we can continue to deliver thoughtful, rigorous and independent science journalism to you. In an era of viral misinformation, this work is crucial. If you value what we do, I hope you’ll consider joining us as a subscriber

Thank you,

Jeanna Bryner, Editor in Chief, Scientific American

Subscribe